The Unfortunate Demise of Theranos

Think Compliance discusses the unfortunate demise of Theranos and how Theranos’ leaders led investors, employees, and Board members to believe their business was going to change the world. 

For our new listeners, Compliatric created this podcast series to assist healthcare and compliance professionals in building their programs. In each Podcast, we discuss a new compliance topic and provide insight on how to ensure your organization is following best practices.

 
 

Mastering Compliance

March 18th, 2026

10:00 AM PT // 1:00 PM ET

Proving Program Effectiveness Under Regulatory Scrutiny

Regulators are no longer satisfied with documentation alone; they want evidence that your compliance program actively prevents, detects, and corrects risk. Investigators expect to see how issues are identified early, investigated thoroughly, corrected effectively, and monitored over time. Boards demand measurable insight, and leadership needs confidence that exposure is managed before it becomes a liability. The standard has shifted from activity to impact.